Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
Treatment options for metastatic melanoma are limited. Here the authors show that combining an immunostimulant adenovirus, currently in clinical trials for leukemia, with immune checkpoints blockade (ICB) results in systemic eradication of ICB resistant melanoma tumours from both skin and brain of m...
Enregistré dans:
Auteurs principaux: | Manisha Singh, Christina Vianden, Mark J. Cantwell, Zhimin Dai, Zhilan Xiao, Meenu Sharma, Hiep Khong, Ashvin R. Jaiswal, Faisal Faak, Yared Hailemichael, L. M. E. Janssen, Uddalak Bharadwaj, Michael A. Curran, Adi Diab, Roland L. Bassett, David J. Tweardy, Patrick Hwu, Willem W. Overwijk |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/91b84c7ca48048a5926a4f18a85bbaa3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
par: Meenu Sharma, et autres
Publié: (2020) -
Trial watch: intratumoral immunotherapy
par: Juliette Humeau, et autres
Publié: (2021) -
Intratumoral heterogeneity and clonal evolution in liver cancer
par: Bojan Losic, et autres
Publié: (2020) -
Clinical significance of intratumor heterogeneity for gynecological carcinoma
par: Ying-Chao Yang, et autres
Publié: (2015) -
Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
par: Sharanya Maanasi Kalasekar, et autres
Publié: (2021)